Jan Szczogiel

Jan Szczogiel

Auto-generated profile, based on publicly available information

Jan Szczogiel

First Department of Cardiology, Medical University of Silesia, 40-635 Katowice, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TBTomasz Bochenek
Tomasz Bochenek
APAdam Pytlewski
Adam Pytlewski
MLMichał Lelek
Michał Lelek
BGBartosz Gruchlik
Bartosz Gruchlik
JSJan Szczogiel
Jan Szczogiel
Katarzyna Mizia-StecKatarzyna Mizia-Stec
Katarzyna Mizia-Stec
Background: Diagnostic angiography of coronary arteries is one of the most common procedures in invasive cardiology and is mainly performed via the radial artery. Rapid improvements in the quality of the equipment and operator’s experience have changed the landscape of this procedure. Methods: In this study, 284 patients were analyzed to determine whether heparin administration should be a necessity for all patients to prevent radial artery occlusion (RAO). Moreover, the possible influence of 51 other factors on RAO was analyzed. Results: This study revealed that heparin administration does not have a significant impact on RAO incidence (p = 0.131). However, it was found that a longer fluoroscopy time (p < 0.001) and smaller (5F) vascular sheath (p = 0.001) might serve as protective factors against RAO. On the other hand, a greater number of catheters (p < 0.001), greater compression time (p = 0.001), wider (6F) vascular sheath (p = 0.002), spasm occurrence (p = 0.001), spasmolytic administration (p < 0.001) and atherosclerotic changes in the radial artery (p = 0.005) were risk factors for RAO. Conclusions: This study demonstrates the need for a more personalized approach to the patient when analyzing the individual risk of RAO. In our opinion, it is possible to omit heparin in cases of patients with an initial low risk of RAO or possible adverse drug reactions during diagnostic angiography.